Nemtabrutinib With Rituximab for the Treatment of Patients With Mantle Cell Lymphoma

NCT06572618 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

27

Enrollment

OTHER

Sponsor class

Conditions

Mantle Cell Lymphoma

Interventions

PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Biopsy
DRUG: Nemtabrutinib
PROCEDURE: Positron Emission Tomography and Computed Tomography Scan
BIOLOGICAL: Rituximab

Sponsor

City of Hope Medical Center

Collaborators

[object Object]